Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Panacea Life Sciences HoldingsPLSH | Open-market buy | 23/09/18 | 23/09/20 | 20,000 sh | $0.24 | $4,800 | +1.3% | |
Panacea Life Sciences HoldingsPLSH | Open-market buy | 23/06/09 | 23/06/12 | 3,000 sh | $0.43 | $1,290 | +0.2% | |
Panacea Life Sciences HoldingsPLSH | Open-market buy | 23/05/19–23/05/23 | 23/05/23 | 6,500 sh3 trades | $0.51avg. | $3,325 | +0.9% | |
Panacea Life Sciences HoldingsPLSH | Open-market buy | 23/05/05–23/05/09 | 23/05/09 | 15,300 sh3 trades | $0.47avg. | $7,154 | +2.1% | |
Panacea Life Sciences HoldingsPLSH | Open-market buy | 23/04/25–23/04/26 | 23/04/26 | 10,000 sh3 trades | $0.39avg. | $3,850 | +1.4% | |
Panacea Life Sciences HoldingsPLSH | Open-market buy | 23/04/03–23/04/05 | 23/04/06 | 6,700 sh3 trades | $0.34avg. | $2,305 | +0.9% | |
Panacea Life Sciences HoldingsPLSH | Open-market buy | 23/02/26–23/02/27 | 23/03/01 | 4,000 sh3 trades | $0.18avg. | $720 | +0.6% |